Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000553087 | SCV000655871 | likely benign | Combined oxidative phosphorylation defect type 27 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000553087 | SCV001524878 | uncertain significance | Combined oxidative phosphorylation defect type 27 | 2019-06-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV001566887 | SCV001790474 | uncertain significance | not provided | 2020-02-10 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Prevention |
RCV003935538 | SCV004755454 | likely benign | CARS2-related disorder | 2020-01-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |